Calcium Gluconate (Phebra)


What it is used for

Calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. Parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. It can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. IV injections have been used in the treatment of acute renal biliary and intestinal colic. Calcium has been used as an inotrope in cardiac resuscitation. They may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.


How to take it

The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.

  • Store below 30 degrees Celsius
  • Do not Refrigerate
  • Shelf lifetime is 18 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.

  • Store below 30 degrees Celsius
  • Do not Refrigerate
  • Shelf lifetime is 18 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Do I need a prescription?

We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is Not Scheduled.


Visual appearance

Clear colourless solution

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments